Bio‐marker detection redundancy improves sensitivity

Liquid biopsy for biomarker detection has the potential to revolutionise the management of cancer by reducing the time that tumours grow and metastasize undetected and untreated. As a relatively less invasive test, the frequency of testing is constrained more by the cost and ease of analysis, which...